3U6I - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 58A

Authors :   S. F. Bellon, D. A. Whittington, A. L. Long

Date :   12 Oct 11 (Deposition) - 22 Feb 12 (Release) - 23 May 12 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.10

Chains :   Asym. Unit : A
Biol. Unit 1: A  (1x)
Biol. Unit 2: A  (2x)

Keywords :   Kinase Domain, Phosphotransferase, Cancer, Hepatocyte Growth Factor, Transferase-Transferase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   M. H. Norman, L. Liu, M. Lee, N. Xi, I. Fellows, N. D. D'Angelo, C. Dominguez, K. Rex, S. F. Bellon, T. S. Kim, I. Dussault
Structure-Based Design Of Novel Class Ii C-Met Inhibitors: 1. Identification Of Pyrazolone-Based Derivatives.
J. Med. Chem. V. 55 1858 2012
PubMed-ID: 22320343 | Reference-DOI: 10.1021/JM201330U

Molecule 1 - HEPATOCYTE GROWTH FACTOR RECEPTOR
	Chains	:	A
	EC Number	:	2.7.10.1
	Engineered	:	YES
	Expression System	:	TRICHOPLUSIA NI
	Expression System Plasmid	:	PFASTBAC1
	Expression System Taxid	:	7111
	Expression System Vector Type	:	BACULOVIRUS
	Fragment	:	UNP RESIDUES 1048-1315
	Gene	:	MET
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET

		1
Asymmetric Unit	:	A
Biological Unit 1 (1x)	:	A
Biological Unit 2 (2x)	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (1, 1)

No.	Name	Count	Type	Full Name
1	044	1	Ligand/Ion	N-{3-FLUORO-4-[(7-METHOXYQUINOLIN-4-YL)OXY]PHENYL}-1-[(2R)-2-HYDROXYPROPYL]-5-METHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXAMIDE

Biological Unit 1 (1, 1)

No.	Name	Count	Type	Full Name
1	044	1	Ligand/Ion	N-{3-FLUORO-4-[(7-METHOXYQUINOLIN-4-YL)OXY]PHENYL}-1-[(2R)-2-HYDROXYPROPYL]-5-METHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXAMIDE

Biological Unit 2 (1, 2)

No.	Name	Count	Type	Full Name
1	044	2	Ligand/Ion	N-{3-FLUORO-4-[(7-METHOXYQUINOLIN-4-YL)OXY]PHENYL}-1-[(2R)-2-HYDROXYPROPYL]-5-METHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXAMIDE

Asymmetric Unit (1, 1)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	HOH A:93 , ILE A:1084 , PHE A:1089 , VAL A:1092 , ALA A:1108 , PHE A:1124 , GLU A:1127 , GLY A:1128 , MET A:1131 , LEU A:1140 , VAL A:1155 , LEU A:1157 , PRO A:1158 , TYR A:1159 , MET A:1160 , GLY A:1163 , MET A:1211 , ALA A:1221 , ASP A:1222 , PHE A:1223 , GLY A:1224	BINDING SITE FOR RESIDUE 044 A 1

(no "SS Bond" information available for 3U6I)

(no "Cis Peptide Bond" information available for 3U6I)

Asymmetric Unit (13, 13)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_032485	V	1092	I	MET_HUMAN	Disease (RCCP)	786202724	A	V	1092	I
02	UniProt	VAR_032486	H	1094	L	MET_HUMAN	Disease (RCCP)	---	A	H	1094	L
03	UniProt	VAR_032487	H	1094	R	MET_HUMAN	Disease (RCCP)	121913243	A	H	1094	R
04	UniProt	VAR_032488	H	1094	Y	MET_HUMAN	Disease (RCCP)	121913244	A	H	1094	Y
05	UniProt	VAR_032489	H	1106	D	MET_HUMAN	Disease (RCCP)	---	A	H	1106	D
06	UniProt	VAR_006286	M	1131	T	MET_HUMAN	Disease (RCCP)	121913668	A	M	1131	T
07	UniProt	VAR_032490	T	1173	I	MET_HUMAN	Disease (HCC)	121913675	A	T	1173	I
08	UniProt	VAR_006287	V	1188	L	MET_HUMAN	Disease (RCCP)	121913669	A	V	1188	L
09	UniProt	VAR_006288	L	1195	V	MET_HUMAN	Disease (RCCP)	121913673	A	L	1195	V
10	UniProt	VAR_006289	V	1220	I	MET_HUMAN	Disease (RCCP)	121913670	A	V	1220	I
11	UniProt	VAR_032493	M	1250	I	MET_HUMAN	Disease (HCC)	121913676	A	M	1250	I
12	UniProt	VAR_006294	M	1250	T	MET_HUMAN	Disease (RCCP)	121913245	A	M	1250	T
13	UniProt	VAR_064857	V	1294	I	MET_HUMAN	Unclassified	---	A	V	1294	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (13, 13)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_032485	V	1092	I	MET_HUMAN	Disease (RCCP)	786202724	A	V	1092	I
02	UniProt	VAR_032486	H	1094	L	MET_HUMAN	Disease (RCCP)	---	A	H	1094	L
03	UniProt	VAR_032487	H	1094	R	MET_HUMAN	Disease (RCCP)	121913243	A	H	1094	R
04	UniProt	VAR_032488	H	1094	Y	MET_HUMAN	Disease (RCCP)	121913244	A	H	1094	Y
05	UniProt	VAR_032489	H	1106	D	MET_HUMAN	Disease (RCCP)	---	A	H	1106	D
06	UniProt	VAR_006286	M	1131	T	MET_HUMAN	Disease (RCCP)	121913668	A	M	1131	T
07	UniProt	VAR_032490	T	1173	I	MET_HUMAN	Disease (HCC)	121913675	A	T	1173	I
08	UniProt	VAR_006287	V	1188	L	MET_HUMAN	Disease (RCCP)	121913669	A	V	1188	L
09	UniProt	VAR_006288	L	1195	V	MET_HUMAN	Disease (RCCP)	121913673	A	L	1195	V
10	UniProt	VAR_006289	V	1220	I	MET_HUMAN	Disease (RCCP)	121913670	A	V	1220	I
11	UniProt	VAR_032493	M	1250	I	MET_HUMAN	Disease (HCC)	121913676	A	M	1250	I
12	UniProt	VAR_006294	M	1250	T	MET_HUMAN	Disease (RCCP)	121913245	A	M	1250	T
13	UniProt	VAR_064857	V	1294	I	MET_HUMAN	Unclassified	---	A	V	1294	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (13, 26)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_032485	V	1092	I	MET_HUMAN	Disease (RCCP)	786202724	A	V	1092	I
02	UniProt	VAR_032486	H	1094	L	MET_HUMAN	Disease (RCCP)	---	A	H	1094	L
03	UniProt	VAR_032487	H	1094	R	MET_HUMAN	Disease (RCCP)	121913243	A	H	1094	R
04	UniProt	VAR_032488	H	1094	Y	MET_HUMAN	Disease (RCCP)	121913244	A	H	1094	Y
05	UniProt	VAR_032489	H	1106	D	MET_HUMAN	Disease (RCCP)	---	A	H	1106	D
06	UniProt	VAR_006286	M	1131	T	MET_HUMAN	Disease (RCCP)	121913668	A	M	1131	T
07	UniProt	VAR_032490	T	1173	I	MET_HUMAN	Disease (HCC)	121913675	A	T	1173	I
08	UniProt	VAR_006287	V	1188	L	MET_HUMAN	Disease (RCCP)	121913669	A	V	1188	L
09	UniProt	VAR_006288	L	1195	V	MET_HUMAN	Disease (RCCP)	121913673	A	L	1195	V
10	UniProt	VAR_006289	V	1220	I	MET_HUMAN	Disease (RCCP)	121913670	A	V	1220	I
11	UniProt	VAR_032493	M	1250	I	MET_HUMAN	Disease (HCC)	121913676	A	M	1250	I
12	UniProt	VAR_006294	M	1250	T	MET_HUMAN	Disease (RCCP)	121913245	A	M	1250	T
13	UniProt	VAR_064857	V	1294	I	MET_HUMAN	Unclassified	---	A	V	1294	I

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (2, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	PROTEIN_KINASE_ATP	PS00107	Protein kinases ATP-binding region signature.	MET_HUMAN	1084-1110	1	A:1084-1110
2	PROTEIN_KINASE_TYR	PS00109	Tyrosine protein kinases specific active-site signature.	MET_HUMAN	1200-1212	1	A:1200-1212

Biological Unit 1 (2, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	PROTEIN_KINASE_ATP	PS00107	Protein kinases ATP-binding region signature.	MET_HUMAN	1084-1110	1	A:1084-1110
2	PROTEIN_KINASE_TYR	PS00109	Tyrosine protein kinases specific active-site signature.	MET_HUMAN	1200-1212	1	A:1200-1212

Biological Unit 2 (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	PROTEIN_KINASE_ATP	PS00107	Protein kinases ATP-binding region signature.	MET_HUMAN	1084-1110	2	A:1084-1110
2	PROTEIN_KINASE_TYR	PS00109	Tyrosine protein kinases specific active-site signature.	MET_HUMAN	1200-1212	2	A:1200-1212

Asymmetric Unit (7, 7)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1c	ENST00000397752	1c	ENSE00001865305	chr7:116312446-116312631	186	MET_HUMAN	-	0	0	-	-
1.3c	ENST00000397752	3c	ENSE00001238915	chr7:116339125-116340338	1214	MET_HUMAN	1-400	400	0	-	-
1.6	ENST00000397752	6	ENSE00000717722	chr7:116371722-116371913	192	MET_HUMAN	401-464	64	0	-	-
1.7	ENST00000397752	7	ENSE00000717724	chr7:116380004-116380138	135	MET_HUMAN	465-509	45	0	-	-
1.8	ENST00000397752	8	ENSE00000717726	chr7:116380906-116381079	174	MET_HUMAN	510-567	58	0	-	-
1.9b	ENST00000397752	9b	ENSE00000717728	chr7:116395409-116395569	161	MET_HUMAN	568-621	54	0	-	-
1.10	ENST00000397752	10	ENSE00000717730	chr7:116397491-116397593	103	MET_HUMAN	621-655	35	0	-	-
1.11b	ENST00000397752	11b	ENSE00000717732	chr7:116397692-116397828	137	MET_HUMAN	656-701	46	0	-	-
1.12a	ENST00000397752	12a	ENSE00000717735	chr7:116398513-116398674	162	MET_HUMAN	701-755	55	0	-	-
1.13b	ENST00000397752	13b	ENSE00001530016	chr7:116399445-116399544	100	MET_HUMAN	755-788	34	0	-	-
1.14	ENST00000397752	14	ENSE00000717791	chr7:116403104-116403322	219	MET_HUMAN	789-861	73	0	-	-
1.15a	ENST00000397752	15a	ENSE00000717803	chr7:116409699-116409845	147	MET_HUMAN	862-910	49	0	-	-
1.16	ENST00000397752	16	ENSE00000717811	chr7:116411552-116411708	157	MET_HUMAN	911-963	53	0	-	-
1.17	ENST00000397752	17	ENSE00000717833	chr7:116411903-116412043	141	MET_HUMAN	963-1010	48	0	-	-
1.18b	ENST00000397752	18b	ENSE00000717861	chr7:116414935-116415165	231	MET_HUMAN	1010-1087	78	1	A:1051-1087	37
1.19	ENST00000397752	19	ENSE00000717879	chr7:116417443-116417523	81	MET_HUMAN	1087-1114	28	1	A:1087-1114	28
1.20	ENST00000397752	20	ENSE00000717895	chr7:116418830-116419011	182	MET_HUMAN	1114-1174	61	1	A:1114-1174	61
1.21	ENST00000397752	21	ENSE00000717902	chr7:116422042-116422151	110	MET_HUMAN	1175-1211	37	1	A:1175-1211	37
1.22	ENST00000397752	22	ENSE00000717928	chr7:116423358-116423523	166	MET_HUMAN	1211-1266	56	1	A:1211-1266 (gaps)	56
1.23	ENST00000397752	23	ENSE00000717937	chr7:116435709-116435845	137	MET_HUMAN	1267-1312	46	1	A:1267-1312	46
1.24b	ENST00000397752	24b	ENSE00000881894	chr7:116435941-116438440	2500	MET_HUMAN	1312-1390	79	1	A:1312-1351	40

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:281
 aligned with MET_HUMAN | P08581 from UniProtKB/Swiss-Prot  Length:1390

    Alignment length:301
                                  1060      1070      1080      1090      1100      1110      1120      1130      1140      1150      1160      1170      1180      1190      1200      1210      1220      1230      1240      1250      1260      1270      1280      1290      1300      1310      1320      1330      1340      1350 
           MET_HUMAN   1051 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 1351
               SCOP domains d3u6ia_ A: Hepatocyte growth factor receptor, c-MET                                                                                                                                                                                                                                                           SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ........hhhhhhhhh........eeeeeeeee......eeeeeeee.....eeeeeeee.....hhhhhhhhhhhhhhhhhh.........eee.......eeeee.....hhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee....--------------------.hhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhh....... Sec.struct. author
             SAPs(SNPs) (1) -----------------------------------------I-L-----------D------------------------T-----------------------------------------I--------------L------V------------------------I-----------------------------I-------------------------------------------I--------------------------------------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------R-----------------------------------------------------------------------------------------------------------------------------------------------------------T----------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------Y----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE ---------------------------------PROTEIN_KINASE_ATP         -----------------------------------------------------------------------------------------PROTEIN_KINAS------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.18b  PDB: A:1051-1087         --------------------------Exon 1.20  PDB: A:1114-1174 UniProt: 1114-1174               Exon 1.21  PDB: A:1175-1211          -------------------------------------------------------Exon 1.23  PDB: A:1267-1312 UniProt: 1267-1312--------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.19  PDB: A:1087-1114 ------------------------------------------------------------------------------------------------Exon 1.22  PDB: A:1211-1266 (gaps) UniProt: 1211-1266   ---------------------------------------------Exon 1.24b  PDB: A:1312-1351             Transcript 1 (2)
                3u6i A 1051 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG--------------------LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 1351
                                  1060      1070      1080      1090      1100      1110      1120      1130      1140      1150      1160      1170      1180      1190      1200      1210      1220   |     -         -    | 1250      1260      1270      1280      1290      1300      1310      1320      1330      1340      1350 
                                                                                                                                                                                                      1224                 1245

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a+b) (23004)

Fold: Protein kinase-like (PK-like) (2589)

Superfamily: Protein kinase-like (PK-like) (2589)

Family: Protein kinases, catalytic subunit (1977)

Protein domain: Hepatocyte growth factor receptor, c-MET (34)

Human (Homo sapiens) [TaxId: 9606] (34)

d3u6ia_

(no "CATH Domain" information available for 3U6I)

(no "Pfam Domain" information available for 3U6I)

Asymmetric Unit(hide GO term definitions)

Chain A (MET_HUMAN | P08581)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0005008	hepatocyte growth factor-activated receptor activity	Combining with hepatocyte growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0019903	protein phosphatase binding	Interacting selectively and non-covalently with any protein phosphatase.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0048754	branching morphogenesis of an epithelial tube	The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
	GO:0008283	cell proliferation	The multiplication or reproduction of cells, resulting in the expansion of a cell population.
	GO:0007166	cell surface receptor signaling pathway	A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0001886	endothelial cell morphogenesis	The change in form (cell shape and size) that occurs during the differentiation of an endothelial cell.
	GO:0048012	hepatocyte growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands.
	GO:0010507	negative regulation of autophagy	Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
	GO:1901299	negative regulation of hydrogen peroxide-mediated programmed cell death	Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0050918	positive chemotaxis	The directed movement of a motile cell or organism towards a higher concentration of a chemical.
	GO:2001028	positive regulation of endothelial cell chemotaxis	Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0071526	semaphorin-plexin signaling pathway	A series of molecular signals generated as a consequence of a semaphorin receptor (composed of a plexin and a neurophilin) binding to a semaphorin ligand.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
	GO:0009925	basal plasma membrane	The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		044	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 3u6i)

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3u6i
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	MET_HUMAN \| P08581
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.10.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	114550
		Disease Information	:	OMIM
	605074
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	MET_HUMAN \| P08581
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 1)

Sites (1, 1)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (13, 13)

PROSITE Motifs (2, 2)

Exons (7, 7)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (33, 33)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File